Proposed disc zone breakpoints for doripenem for use with the BSAC disc susceptibility testing method.

Sir, Doripenem is a new carbapenem, recently licensed in the European Union for treatment of nosocomial pneumonia (including ventilator-associated pneumonia), complicated intraabdominal infections and complicated urinary tract infections. A 10 mg doripenem disc has been proposed for routine susceptibility testing. We determined provisional zone breakpoints… CONTINUE READING